HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products.
In virus models explored in detail in mice, CTL typically focus on a few immunodominant determinants. In this study we use a multipronged approach to understand the diversity of CTL responses to vaccinia virus, a prototypic poxvirus with a genome approximately 20-fold larger than that of the model R...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2005
|
| _version_ | 1826271722918117376 |
|---|---|
| author | Pasquetto, V Bui, H Giannino, R Banh, C Mirza, F Sidney, J Oseroff, C Tscharke, D Irvine, K Bennink, JR Peters, B Southwood, S Cerundolo, V Grey, H Yewdell, J Sette, A |
| author_facet | Pasquetto, V Bui, H Giannino, R Banh, C Mirza, F Sidney, J Oseroff, C Tscharke, D Irvine, K Bennink, JR Peters, B Southwood, S Cerundolo, V Grey, H Yewdell, J Sette, A |
| author_sort | Pasquetto, V |
| collection | OXFORD |
| description | In virus models explored in detail in mice, CTL typically focus on a few immunodominant determinants. In this study we use a multipronged approach to understand the diversity of CTL responses to vaccinia virus, a prototypic poxvirus with a genome approximately 20-fold larger than that of the model RNA viruses typically studied in mice. Based on predictive computational algorithms for peptide binding to HLA supertypes, we synthesized a panel of 2889 peptides to begin to create an immunomic map of human CTL responses to poxviruses. Using this panel in conjunction with CTLs from vaccinia virus-infected HLA transgenic mice, we identified 14 HLA-A*0201-, 4 HLA-A*1101-, and 3 HLA-B*0702-restricted CD8(+) T cell determinants distributed over 20 distinct proteins. These peptides were capable of binding one or multiple A2, A3, and B7 supertype molecules with affinities typical of viral determinants. Surprisingly, many of the viral proteins recognized are predicted to be late gene products, in addition to the early intermediate gene products expected. Nearly all of the determinants identified have identical counterparts encoded by modified vaccinia virus Ankara as well as variola virus, the agent of smallpox. These findings have implications for the design of new smallpox vaccines and the understanding of immune responses to large DNA viruses in general. |
| first_indexed | 2024-03-06T22:01:10Z |
| format | Journal article |
| id | oxford-uuid:4ea1cb9b-4f88-4e56-87a8-b835fdc6c0c8 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:01:10Z |
| publishDate | 2005 |
| record_format | dspace |
| spelling | oxford-uuid:4ea1cb9b-4f88-4e56-87a8-b835fdc6c0c82022-03-26T16:02:18ZHLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4ea1cb9b-4f88-4e56-87a8-b835fdc6c0c8EnglishSymplectic Elements at Oxford2005Pasquetto, VBui, HGiannino, RBanh, CMirza, FSidney, JOseroff, CTscharke, DIrvine, KBennink, JRPeters, BSouthwood, SCerundolo, VGrey, HYewdell, JSette, AIn virus models explored in detail in mice, CTL typically focus on a few immunodominant determinants. In this study we use a multipronged approach to understand the diversity of CTL responses to vaccinia virus, a prototypic poxvirus with a genome approximately 20-fold larger than that of the model RNA viruses typically studied in mice. Based on predictive computational algorithms for peptide binding to HLA supertypes, we synthesized a panel of 2889 peptides to begin to create an immunomic map of human CTL responses to poxviruses. Using this panel in conjunction with CTLs from vaccinia virus-infected HLA transgenic mice, we identified 14 HLA-A*0201-, 4 HLA-A*1101-, and 3 HLA-B*0702-restricted CD8(+) T cell determinants distributed over 20 distinct proteins. These peptides were capable of binding one or multiple A2, A3, and B7 supertype molecules with affinities typical of viral determinants. Surprisingly, many of the viral proteins recognized are predicted to be late gene products, in addition to the early intermediate gene products expected. Nearly all of the determinants identified have identical counterparts encoded by modified vaccinia virus Ankara as well as variola virus, the agent of smallpox. These findings have implications for the design of new smallpox vaccines and the understanding of immune responses to large DNA viruses in general. |
| spellingShingle | Pasquetto, V Bui, H Giannino, R Banh, C Mirza, F Sidney, J Oseroff, C Tscharke, D Irvine, K Bennink, JR Peters, B Southwood, S Cerundolo, V Grey, H Yewdell, J Sette, A HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. |
| title | HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. |
| title_full | HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. |
| title_fullStr | HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. |
| title_full_unstemmed | HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. |
| title_short | HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. |
| title_sort | hla a 0201 hla a 1101 and hla b 0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products |
| work_keys_str_mv | AT pasquettov hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT buih hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT gianninor hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT banhc hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT mirzaf hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT sidneyj hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT oseroffc hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT tscharked hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT irvinek hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT benninkjr hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT petersb hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT southwoods hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT cerundolov hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT greyh hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT yewdellj hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts AT settea hlaa0201hlaa1101andhlab0702transgenicmicerecognizenumerouspoxvirusdeterminantsfromawidevarietyofviralgeneproducts |